LIVE GEOS (ALWAYS UP TO DATE) https://partners.subjectwell.com/publishers/geos_report/087fbd8a-a3a1-490d-af5d-66ff6a58c94c Age Range: 4-17 Gender: Any **ALL COPY AND CREATIVE (ASIDE FROM WHAT IS PROVIDED) MUST BE SUBMITTED TO [email protected] FOR APPROVAL PRIOR TO GOING LIVE** Study Description: This study is testing an investigational medication for people with a confirmed peanut allergy compared to a placebo. Participants will receive either investigational medication being tested in the study or a placebo for 9 months. Additional procedures include vital signs, physical examinations, laboratory tests, lung function assessments and e-diary entries. Total participation will last up to 1 year and 4 months with approximately 14 clinic visits throughout the study. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost. Qualifications: - Child cannot have taken peanut oral immunotherepy in the last 12 months - Must consent to an oral food challenge with peanut proteins to illicit an allergic response to test child's reactivity to peanuts

ClicksAdv, LLC